Kaisers 2026 formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
Accessed at www.who.int/news/item/19-06-2024-medical-product-alert-n-2-2024falsifiedozempic-(semaglutide)
Additionally, BMI reduction through GLP-1 RAs may lower the risk of perioperative venous thromboembolism (VTE), although it remains unclear whether these agents exert direct effects on coagulation pathways [104]
For compounded semaglutide, the time to see results may vary, depending on the formulation and individual response, but theres no official data on its timeline
Also avoid added sugar in beverages and snacks, highly processed foods, fast food, and alcohol, especially during dose titration